5 months ago
1
There is nary shortage of indispensable anti-tuberculosis (anti-TB) drugs similar Rifampicin and Ethambutol successful the cardinal and State warehouses, Union Minister of State for Health Anupriya Patel told the Rajya Sabha connected Tuesday (December 9, 2025).
She was responding to a question connected whether determination has been immoderate shortage of cardinal anti-TB drugs successful caller months, the reasons for hold successful tender finalisation by the Central Tuberculosis Division and the measures being taken to guarantee uninterrupted cause proviso nether the National Tuberculosis Elimination Programme (NTEP).
In a written reply, Ms. Patel said the NTEP is being implemented nether the aegis of National Health Mission (NHM) crossed the country.
Swing, but bash not miss: connected India and the WHO’s Global Tuberculosis Report 2025
"There are nary shortages of immoderate cardinal anti-TB drugs, including for Rifampicin and Ethambutol, successful the Central and State warehouses. Rate declaration exemplary has been established for each drugs including newer and shorter regimen drugs for 2025-27, portion ensuring capable buffer," she stated.
Several steps person been taken to fortify the proviso concatenation of prime drugs, the effect stated.
These see timely submission of indents to the procurement agency, real-time tracking of cause availability and utilisation via the Drugs and Vaccines Distribution Management System (DVDMS), regular carnal banal verification by state, district, and nationalist teams during tract visits, and supervision astatine some State and territory levels.
“Coordination with suppliers done the procurement bureau to guarantee timely proviso of drugs, indispensable diagnostics, reagents and kits has besides been strengthened,” the Minister stated.
As per the World Health Organisation's (WHO) Global TB Report 2025, India recorded an estimated 21.7 lakh tuberculosis cases, and astir 3 lakh deaths owed to the corruption successful 2024.
